As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure

 
• By David Wild
  
Waiting For Market Uptake Of Competing Gene-Based Therapies • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Market Access

More from In Vivo